These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8186337)
41. Effect of lansoprazole on peptic ulcers. Ohashi T; Sakata J; Haraguchi Y; Eto T J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350 [TBL] [Abstract][Full Text] [Related]
42. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials. Classen M; Dammann HG; Domschke W; Hüttemann W; Londong W; Rehner M; Simon B; Witzel L; Berger J Hepatogastroenterology; 1985 Oct; 32(5):243-5. PubMed ID: 3908262 [TBL] [Abstract][Full Text] [Related]
43. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole. Mee AS; Rowley JL Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084 [TBL] [Abstract][Full Text] [Related]
44. [Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats]. Murakami I; Asano S; Yukishige K; Nagaya H; Satoh H; Inatomi N Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):323-32. PubMed ID: 9017686 [TBL] [Abstract][Full Text] [Related]
45. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study. Schepp W; Classen M Scand J Gastroenterol; 1995 Jun; 30(6):511-4. PubMed ID: 7569755 [TBL] [Abstract][Full Text] [Related]
46. Effectiveness of ranitidine 150 mg at bedtime as maintenance therapy for healed gastric ulcers. Sue SO; Dawson DM; Brown JA; Wood DR; Kleoudis CS Clin Ther; 1996; 18(6):1175-83. PubMed ID: 9001834 [TBL] [Abstract][Full Text] [Related]
47. A double-blind, randomized, parallel group study of omeprazole and ranitidine in Korean patients with gastric ulcer. Choi KW; Sun HS; Yoon CM; Park KN; Min YI; Chang R; Lee SI; Chung JM; Yang US; Wong EC J Gastroenterol Hepatol; 1994; 9(2):118-23. PubMed ID: 8003642 [TBL] [Abstract][Full Text] [Related]
48. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Jones RH; Baxter G Aliment Pharmacol Ther; 1997 Jun; 11(3):541-6. PubMed ID: 9218080 [TBL] [Abstract][Full Text] [Related]
49. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group. Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695 [TBL] [Abstract][Full Text] [Related]
50. Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies. Berstad A; Hatlebakk JG Aliment Pharmacol Ther; 1993; 7 Suppl 1():34-6, discussion 61-6. PubMed ID: 8490077 [TBL] [Abstract][Full Text] [Related]
51. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer. Avner DL; Movva R; Nelson KJ; McFarland M; Berry W; Erfling W Am J Gastroenterol; 1995 Aug; 90(8):1289-94. PubMed ID: 7639232 [TBL] [Abstract][Full Text] [Related]
52. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial. Okai T; Sawabu N; Songür Y; Motoo Y; Watanabe H J Clin Gastroenterol; 1995; 20 Suppl 2():S32-5. PubMed ID: 7594335 [TBL] [Abstract][Full Text] [Related]
53. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration. Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter. Aoyama N; Kinoshita Y; Misaki F; Himeno S; Kasuga M; Chiba T J Clin Gastroenterol; 1995; 20 Suppl 2():S86-9. PubMed ID: 7594351 [TBL] [Abstract][Full Text] [Related]
55. Histological aspects and healing rates of gastric ulcers treated with omeprazole 20 mg once daily or ranitidine 150 mg B.I.D. Rossini FP; Spandre M; Gemme C; Cavallero M; Bertone A; Coverlizza S; Risio M Panminerva Med; 1989; 31(2):94-6. PubMed ID: 2797847 [TBL] [Abstract][Full Text] [Related]
56. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity. Arnestad JS; Kleveland PM; Waldum HL Aliment Pharmacol Ther; 1997 Apr; 11(2):355-8. PubMed ID: 9146775 [TBL] [Abstract][Full Text] [Related]
57. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients. Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902 [TBL] [Abstract][Full Text] [Related]
58. Effect of omeprazole, lansoprazole, and ranitidine on the DNA synthesis of mononuclear cells. Peddicord TE; Olsen KM; Collier DS Crit Care Med; 1999 Jan; 27(1):90-4. PubMed ID: 9934899 [TBL] [Abstract][Full Text] [Related]
59. Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat. Kuwayama H; Matsuo Y; Eastwood GL Am J Med; 1991 Aug; 91(2A):15S-19S. PubMed ID: 1882902 [TBL] [Abstract][Full Text] [Related]
60. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study). Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]